Preview

Epilepsy and paroxysmal conditions

Advanced search

SEMA6B-related progressive myoclonus epilepsy in a patient with Klinefelter syndrome

https://doi.org/10.17749/2077-8333/epi.par.con.2024.175

Abstract

In most cases, variants of nucleotide sequence in the SEMA6B gene account for developing the phenotype of progressive myoclonus epilepsy and, to a lesser extent, developmental encephalopathy with or without epilepsy. Loss-of-function variants in nucleotide sequence localized mainly in exon 17 of the SEMA6B gene contribute to production of aberrant proteins with “toxic” functions. A clinical case of status epilepsy in a patient with a variant in the SEMA6B gene (c.2506delС; p.His836ThrfsTer136; NM_032108.4) is described in the article that expands our knowledge regarding the SEMA6B gene variants resulting in progressive myoclonus epilepsy.

About the Authors

T. V. Kozhanova
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children; Pirogov Russian National Research Medical University
Russian Federation

Tatyana V. Kozhanova – MD, PhD, Leading Researcher, Laboratory Geneticist; Associate Professor, Chair of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics

38 Aviators Str., Moscow 119620, Russia

1 Ostrovityanov Str., Moscow 117997, Russia



S. S. Zhilina
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children; Pirogov Russian National Research Medical University
Russian Federation

Svetlana S. Zhilina – MD, PhD, Leading Researcher, Geneticist; Associate Professor, Chair of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics

38 Aviators Str., Moscow 119620, Russia

1 Ostrovityanov Str., Moscow 117997, Russia



T. I. Meshcheryakova
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children; Pirogov Russian National Research Medical University
Russian Federation

Tatiana I. Meshcheryakova – MD, PhD, Leading Researcher, Geneticist; Associate Professor, Chair of General and Medical Genetics, Faculty of Medicine and Biology

38 Aviators Str., Moscow 119620, Russia

1 Ostrovityanov Str., Moscow 117997, Russia



L. M. Sushko
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children
Russian Federation

Lilia M. Sushko – Neurologist

38 Aviators Str., Moscow 119620, Russia



K. V. Osipova
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children
Russian Federation

Karina V. Osipova – MD, PhD, Head of Neuropsychiatric Department

38 Aviators Str., Moscow 119620, Russia



A. M. Mazur
Genoanalytica LLC
Russian Federation

Aleksandr M. Mazur – PhD (Phys.-Math.), Director For Science

est. 1 bldg. 77 Leninskie Gory, Moscow 119234, Russia



S. S. Fomenko
Genoanalytica LLC
Russian Federation

Sergey S. Fomenko – Bioinformatics Specialist

est. 1 bldg. 77 Leninskie Gory, Moscow 119234, Russia



A. I. Krapivkin
Voyno-Yasenetsky Scientific and Practical Center of Spicialized Medical Care for Children
Russian Federation

Alexey I. Krapivkin – Dr. Med. Sc., Director

38 Aviators Str., Moscow 119620, Russia



N. N. Zavadenko
Pirogov Russian National Research Medical University
Russian Federation

Nikolay N. Zavadenko – Dr. Med. Sc., Professor, Chief of Chair of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics

1 Ostrovityanov Str., Moscow 117997, Russia



References

1. Castellotti B., Canafoglia L., Freri E., et al. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes. Epilepsia Open. 2023; 8 (2): 645–50. https://doi.org/10.1002/epi4.12697.

2. Franceschetti S., Michelucci R., Canafoglia L., et al. Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology. 2014; 82 (5): 405–11. https://doi.org/10.1212/WNL.0000000000000077.

3. Hamanaka K., Imagawa E., Koshimizu E., et al. De novo truncating variants in the last exon of SEMA6B cause progressive myoclonic epilepsy. Am J Hum Genet. 2020; 106 (4): 549–58. https://doi.org/10.1016/j.ajhg.2020.02.011.

4. Yazdani U., Terman J.R. The semaphorins. Genome Biol. 2006; 7: 211. https://doi.org/10.1186/gb-2006-7-3-211.

5. Shu L., Xu Y., Tian Q., et al. A frameshift variant in the SEMA6B gene causes global developmental delay and febrile seizures. Neurosci Bull. 2021; 37 (9): 1357–60. https://doi.org/10.1007/s12264-021-00717-5.

6. Xiaozhen S., Fan Y., Fang Y., et al. Novel truncating and missense variants in SEMA6B in patients with early-onset epilepsy. Front Cell Dev Biol. 2021; 9: 633819. https://doi.org/10.3389/fcell.2021.633819.

7. Duan J., Chen Y., Hu Z., et al. Non-convulsive status epilepticus in SEMA6B-related progressive myoclonic epilepsy: a case report with literature review. Front Pediatr. 2022; 10: 859183. https://doi.org/10.3389/fped.2022.859183.

8. Cordovado A., Schaettin M., Jeanne M., et al. SEMA6B variants cause intellectual disability and alter dendritic spine density and axon guidance. Hum Mol Genet. 2022; 31 (19): 3325–40. https://doi.org/10.1093/hmg/ddac114.

9. Correa R.G., Sasahara R.M., Bengtson M.H., et al. Human semaphoring 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic aciddependent downregulation in glioblastoma cell lines. Genomics. 2001; 73 (3): 343–8. https://doi.org/10.1006/geno.2001.6525.

10. Classification of progressive myoclonus epilepsies and related disorders. Marseille Consensus Group. Ann Neurol. 1990; 28 (1): 113–6. https://doi.org/10.1002/ana.410280129.


Review

For citations:


Kozhanova T.V., Zhilina S.S., Meshcheryakova T.I., Sushko L.M., Osipova K.V., Mazur A.M., Fomenko S.S., Krapivkin A.I., Zavadenko N.N. SEMA6B-related progressive myoclonus epilepsy in a patient with Klinefelter syndrome. Epilepsy and paroxysmal conditions. 2024;16(1):45-53. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2024.175

Views: 805


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)